IM Cannabis

IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC), an international medical cannabis company with operations in Israel and Germany, has announced its board of directors’ approval for a consolidation of its issued and outstanding common shares. The consolidation will convert every six pre-...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1). Q1 2022 Financial Results Revenues were $23.6 million in Q1...

As the business of cannabis grows in size and opportunity, many companies in the space are wondering about the challenges of international expansion. Peter Simeon, partner at Gowling, asked this question of a panel of experts at the Benzinga Cannabis Capital Conference on April 20 at the...